Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores

Practice patterns and outcomes for patients with node-negative hormone receptor-positive breast cancer and intermediate 21-gene Recurrence Scores

Abstract Background The recommendation for chemotherapy in early-stage breast cancer patients has been refined by the 21-gene Recurrence Score. However, uncertainty remains whether patients in the Intermediate Risk category benefit from chemotherapy. Methods We analyzed female patients from the Nati...

Full description

Bibliographic Details
Main Authors: Jonathan Chen, Xian Wu, Paul J. Christos, Silvia Formenti, Himanshu Nagar
Format: Article
Language:English
Published: BMC 2018-04-01
Series:Breast Cancer Research
Subjects:
Breast cancer
Chemotherapy
Intermediate risk
Recurrence Score
National Cancer Database
Online Access:http://link.springer.com/article/10.1186/s13058-018-0957-3

Internet

http://link.springer.com/article/10.1186/s13058-018-0957-3

Similar Items